Skip to content

Clinical trials

Overweight trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: Greece Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20111
20141
20184
20191
20203
20223
20235
20243
20259
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting13
Active, not recruiting3
Not yet recruiting2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company7
Novo Nordisk A/S7
University of Thessaly7
Harokopio University6
Agricultural University of Athens3
National and Kapodistrian University of Athens3
Ascletis Pharma (China) Co., Limited2
Allurion Technologies1
Amgen1
Federico II University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight41
Obesity40
Diabetes Mellitus, Type 24
Hypertension4
Prediabetic State4
Crohn Disease2
Dyslipidemias2
Inflammation2
Atherosclerosis1
Body Weight Changes1

Trials

Showing 26 to 41 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.